Published in Lab Law Weekly, January 12th, 2007
MIVT recently announced remarkable results from preclinical studies of two of its novel biocompatible polymer-free drug-eluting stent coating technologies that matched or even outperformed Cordis' and Boston Scientific's drug eluting stents, according to the report.
The independently conducted 4-week porcine study at the Erasmus University Medical Center in the Netherlands compared stents...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly